jRCT1040220095
Untitled Trial
A study to ascertain changes in blood urimic toxins in chronic kidney disease patients due to dietary treatment with sake lees: Open label pilot randomized controlled trial (Sake lees CKD)
Kanazawa University Hospital·Japan Registry Clinical TrialRecruiting
Study focus
- Disease/Condition
- Chronic kidney disease
- Study type
- Interventional
Sponsor & location
- Primary sponsor
- Kanazawa University Hospital
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
ICD-10 classifications
Chronic kidney diseaseChronic kidney disease, unspecifiedChronic kidney disease, stage 1Chronic kidney disease, stage 4Chronic kidney disease, stage 2
Data source
- Registry
- Japan Registry Clinical Trial
- Trial ID
- jRCT1040220095
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for jRCT1040220095 through Pure Global AI's free database. This phase not specified trial is sponsored by Kanazawa University Hospital and is currently Recruiting. The study focuses on Chronic kidney disease.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Japan Registry Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.